EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion

Arch Endocrinol Metab. 2020 Apr;64(2):185-189. doi: 10.20945/2359-3997000000208. Epub 2020 Mar 27.

Abstract

The EIF1AX gene mutations have been recently associated with papillary thyroid carcinoma and anaplastic thyroid cancer. According with these reports, the gene as been considered as a drive gene for thyroid cancer development. However, the occurrence of these alterations in benign thyroid lesions is not known and is still under investigation. Some authors have already reported the presence of EIF1AX variants in follicular adenomas and hyperplastic nodules. Here, we describe for the first time a case of a man with the EIF1AX c.338-2A>T splice site mutation in an indeterminate FNA lesion with trabecular adenoma at final histology in the absence of other pathogenetic mutations, demonstrating that further studies are required to better understand EIF1AX role in the tumorigenesis of thyroid carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / diagnosis*
  • Adenoma / genetics*
  • Biopsy, Fine-Needle
  • Eukaryotic Initiation Factor-1 / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Thyroid Neoplasms / diagnosis*
  • Thyroid Neoplasms / genetics*

Substances

  • Eukaryotic Initiation Factor-1